Can rasagiline treat symptoms of unsteady walking?

Rasagiline plays an important role in the treatment of Parkinson's disease. Its mechanism of action is to selectively inhibit monoamine oxidase B (MAO-B) in the brain, thereby extending the half-life of dopamine, enhancing neurotransmission, and improving motor symptoms. Since the typical features of Parkinson's disease include bradykinesia, stiffness, tremor and postural instability, "unsteady walking" is often one of the common manifestations in the progression of the disease and is also one of the main factors that decreases the quality of life of patients.

As a monotherapy, rasagiline is mainly used to control early symptoms of Parkinson's disease and can slightly improve walking ability. In the middle and late stages of the disease, it is often used as an auxiliary drug for levodopa treatment to reduce the "switch phenomenon" or movement fluctuations. At this stage, rasagiline helps relieve slowness and pauses when walking by stabilizing dopamine levels in the brain, and has a certain auxiliary effect on "freezing gait".

It should be pointed out that although rasagiline can improve some gait instability caused by dopamine deficiency, its effect on balance disorders caused by structural nerve damage or non-motor factors is limited. In addition, even if some patients take rasagiline, they may still experience walking instability when turning, starting, or suddenly changing speed. In this case, they need to be used in conjunction with other drugs such as Antam, compound levodopa, etc., or combined with physical therapy for gait training.

Therefore, rasagiline can be used as an effective auxiliary treatment for patients with Parkinson's disease who have unstable walking, but its efficacy needs to be evaluated in conjunction with the course of the disease, individual differences, and medication combinations. If rasagiline alone cannot significantly improve gait, multidimensional strategies such as neurological rehabilitation intervention, physical therapy intervention, or the use of walkers should also be considered to comprehensively manage walking function. Patients develop personalized treatment plans under the guidance of doctors to maximize their quality of life.

Reference materials:https://www.azilect.com/